1. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells
   Xin Tian et al, 2017 CrossRef
2. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer
   Yanghua Fan et al, 2017, Clinica Chimica Acta CrossRef
3. Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population
   Tian Yang et al, 2016, Cancer Epidemiology CrossRef
4. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
   Abril Marcela Herrera-Solorio et al, 2017, Clin Epigenet CrossRef
5. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression
   Zhenyao Chen et al, 2017, Cell Death Dis CrossRef
6. LncRNA PANDAR as a prognostic marker in Chinese cancer
   Peng-ju Ma et al, 2017, Clinica Chimica Acta CrossRef
7. Emerging role of long noncoding RNAs in lung cancer: Current status and future prospects
   Hui Tao et al, 2016, Respiratory Medicine CrossRef
8. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosis
   Qian Tan et al, 2017 CrossRef
9. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells.
   Huijun Zeng et al, 2017, Int J Oncol CrossRef
10. Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway
    Bing Wang et al, 2017 CrossRef
11. LncRNAs and cancer
    Rui Zhang et al, 2016 CrossRef
12. Long non-coding RNA MIAT in development and disease: a new player in an old game
    Cheng Sun et al, 2018, J Biomed Sci CrossRef
13. Long non coding RNA XIST as a prognostic cancer marker – A meta-analysis
    Qun Zhou et al, 2018, Clinica Chimica Acta CrossRef
14. Role of long non-coding RNA in drug resistance in non-small cell lung cancer.
    Leirong Wang et al, 2018, Thorac Cancer CrossRef
15. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC
    Xuehao Li et al, 2018, Cell Cycle CrossRef
16. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targettingmiR-377/CASP1 axis
    ZheXing Wang et al, 2018, Biosci. Rep. CrossRef
17. Integrated analysis of lncRNA–mRNA co-expression networks in the α-particle induced carcinogenesis of human branchial epithelial cells
    Xiao-Dan Liu et al, 2018, International Journal of Radiation Biology CrossRef
18. Prediction of biomarkers of oral squamous cell carcinoma using microarray technology
    Guang Li et al, 2017, Sci Rep CrossRef
19. LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge
    Changjiang Feng et al, 2019, Archivos de Bronconeumología CrossRef
20. null
    Anna Roth et al, 2015 CrossRef
21. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma
    Xuhua Xie et al, 2019, Experimental Cell Research CrossRef
22. Long non‐coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation‐dependent repression of CDH1 promoter
    Li‐Ming Gao et al, 2019, J Cell Mol Med CrossRef
23. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
    Xiaoling Tian et al, 2015, BMJ Open CrossRef
24. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies
    Fan Zhang et al, 2016, Tumor Biol. CrossRef
25. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers
    Chenhui Ma et al, 2016, Tumor Biol. CrossRef
26. MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer
    Sara Donzelli et al, 2016, Seminars in Cell & Developmental Biology CrossRef
27. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis
    Yang-Hua Fan et al, 2017, Clinica Chimica Acta CrossRef
28. Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis
    Yang-Hua Fan et al, 2017, Clinica Chimica Acta CrossRef
29. LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge
    Changjiang Feng et al, 2019, Archivos de Bronconeumología (English Edition) CrossRef
30. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers
    Xi Zhou et al, 2019, Medicine CrossRef
31. Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44.
    He Wang et al, 2020, Mol Ther Nucleic Acids CrossRef
32. Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
    Ruizheng Sun et al, 2019, Front. Pharmacol. CrossRef
33. Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures
    Say Li Kong et al, 2019 CrossRef
34. Prognostic Values of Long Noncoding RNA linc00152 in Various Carcinomas: An Updated Systematic Review and Meta‐Analysis
    Han Wang et al, 2020, The Oncol CrossRef
35. Non-coding RNAs in Lung Cancer Chemoresistance
    Priya Mondal et al, 2020, CDM CrossRef
36. Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
    Han Wang et al, 2018, Oncotarget CrossRef
37. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
    Rui-Hua Liu et al, 0 CrossRef
38. Long non-coding RNAs in anti-cancer drug resistance
    Qin-nan Chen et al, 2017, Oncotarget CrossRef
39. BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis
    Yang-Hua Fan et al, 2017, Oncotarget CrossRef
40. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis
    Yang-Hua Fan et al, 2017, Oncotarget CrossRef
41. Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.
    Xiaomin Liu et al, 2017, Oncotarget CrossRef
42. Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis
    Peng-Ju Ma et al, 2017, Oncotarget CrossRef
43. Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer
    Wenhua Xue et al, 2017, Oncotarget CrossRef
44. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3.
    Zhonghua Ma et al, 0 CrossRef
45. LncRNA UCA1 in anti-cancer drug resistance
    Haohao Wang et al, 2017, Oncotarget CrossRef
46. Long non-coding RNAs associated with non-small cell lung cancer
    Yuting Zhan et al, 2017, Oncotarget CrossRef
47. Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer
    Hui Pan et al, 2016, Oncotarget CrossRef
48. Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer
    Ningning Cheng et al, 2015, Oncotarget CrossRef
49. LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers
    Chen Chen et al, 2020, Cancer Letters CrossRef
50. Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer
    Jingjing Shi et al, 2020, Computational Biology and Chemistry CrossRef
51. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting
    Deepti Singh et al, 2020, Mol Biol Rep CrossRef
52. HOTAIR induces EGFR-TKIs Resistance in Non-Small Cell Lung Cancer through Epithelial-Mesenchymal Transition
    Qi Wang et al, 2020, Lung Cancer CrossRef
53. Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review)
    Lin Jiang et al, 2019, Int J Oncol CrossRef
54. LncRNA AWPPH participates in the metastasis of non‑small cell lung cancer by upregulating TGF‑β1 expression
    Yanxia Huo et al, 2019, Oncol Lett CrossRef
55. RNA sequencing uncovers the key long non‑coding RNAs and potential molecular mechanism contributing to XAV939‑mediated inhibition of non‑small cell lung cancer
    Haixiang Yu et al, 2019, Oncol Lett CrossRef
56. lncRNA PVT1 accelerates progression of non‑small cell lung cancer via targeting miRNA‑526b/EZH2 regulatory loop
    Chun Qiu et al, 2019, Oncol Lett CrossRef
57. The correlation between lncRNAs and Helicobacter pylori in gastric cancer
    Narges Dastmalchi et al, 2019 CrossRef
58. Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer
    Manuela La Montagna et al, 2020, Cancer Gene Ther CrossRef
59. Long Noncoding RNA PVT1 Promotes Non–Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression
    Li Wan et al, 2016, Mol Cancer Ther CrossRef
60. Targeting Epigenetics in Lung Cancer.
    Yvonne L Chao et al, 2021, Cold Spring Harb Perspect Med CrossRef
61. The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer
    Junxia Liu et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
62. null
    Yanli Li et al, 2022 CrossRef
63. β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
    Cong Xu et al, 2023, Pharmacological Research CrossRef
64. Long Non-Coding RNAs as Emerging Targets in Lung Cancer
    Jovanka Gencel-Augusto et al, 2023, Cancers CrossRef
65. Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance
    Detian Liu et al, 2023, Front. Genet. CrossRef
66. Long Non-Coding RNAs in Lung Cancer: Unraveling the Molecular Modulators of MAPK Signaling
    Md Sadique Hussain et al, 2023, Pathology - Research and Practice CrossRef
67. Long non-coding RNA and Evolving drug resistance in lung cancer
    Meibin Wang et al, 2023, Heliyon CrossRef
68. Effect of m6A Methylation Modification on IncRNA ENST00000425005 in Doxorubicin Resistance and Epithelial-Mesenchymal Transition Progression in Lung Cancer Cells
    Yuan Wang et al, 2024, j biomed nanotechnol CrossRef
69. Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System
    Valentina Fustaino et al, 2024, IJMS CrossRef